Evidence map›Paper›PMID 31586947›Full record

ArticleSexually transmitted infections2020

Rise and fall of the new variant of

Joost H Smid, Christian L Althaus, Nicola Low, Magnus Unemo, Bjőrn Herrmann

Abstract read
In one paragraph

Article in Sexually transmitted infections, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Decreased chlamydia notifications in six European Union/European Economic Area countries and England, 2024.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  2. Article
  3. Diagnosis of Chlamydia trachomatis genital infections in the era of genomic medicine.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2021
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Joost H SmidInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Christian L AlthausInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland christian.althaus@alumni.ethz.ch.ORCID 0000-0002-5230-6760
Nicola LowInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.ORCID 0000-0003-4817-8986
Magnus UnemoDepartment of Laboratory Medicine, Clinical Microbiology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Bjőrn HerrmannSection of Clinical Bacteriology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.ORCID 0000-0001-8729-2306

Funding

Department of Health RP-PG-0614-20009
6 · The paper itself

Abstract

objectivesA new variant of

methodsWe used a compartmental mathematical model describing the spatial and temporal spread of nvCT and wtCT. We parameterised the model using sexual behaviour data and Swedish spatial and demographic data. We used Bayesian inference to fit the model to surveillance data about reported diagnoses of chlamydia infection in each county and data from four counties that assessed the proportion of nvCT in multiple years.

resultsModel results indicated that nvCT emerged in central Sweden (Dalarna, Gävleborg, Västernorrland), reaching a proportion of 1% of prevalent CT infections in late 2002 or early 2003. The diagnostic selective advantage enabled rapid spread of nvCT in the presence of high treatment rates. After detection, the proportion of nvCT decreased from 30%-70% in AR counties and 5%-20% in counties that Becton Dickinson tests, to around 5% in 2015 in all counties. The decrease in nvCT was consistent with an estimated fitness cost of around 5% in transmissibility or 17% reduction in infectious duration.

conclusionsWe reconstructed the course of a natural experiment in which a mutant strain of

Indexed as

Bayes TheoremChlamydia InfectionsChlamydia trachomatisEpidemicsHumansModels, TheoreticalMutationNucleic Acid Amplification TechniquesPlasmidsPrevalenceSwedenbasic reproduction numberChlamydia trachomatismathematical modelnucleic acid amplification testSweden

Identifiers

PMID31586947
PMCPMC7402554

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.